Integrated analysis revealing genome‑wide chromosomal copy number variation in supraglottic laryngeal squamous cell carcinoma
Authors:
Open Access
- 21 May 2020
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 20 (2) , 1201-1212
Abstract
Laryngeal squamous cell carcinoma (LSCC) is a genetically complex tumor type and one of the leading causes of cancer‑associated disability and mortality. Genetic instability, such as chromosomal instability, is associated with the tumorigenesis of LSCC. Copy number variations (CNVs) have been demonstrated to contribute to the genetic diversity of tumor pathogenesis. Comparative genomic hybridization (CGH) has emerged as a high‑throughput genomic technology that facilitates the aggregation of high‑resolution data of cancer‑associated genomic imbalances. In the present study, a total of 38 primary supraglottic LSCC cases were analyzed by high‑resolution array‑based CGH (aCGH) to improve the understanding of the genetic alterations in LSCC. Additionally, integration with bioinformatic analysis of microarray expression profiling data from the Gene Expression Omnibus (GEO) database provided a fundamental method for the identification of putative target genes. Genomic CNVs were detected in all cases. The size of net genomic imbalances per case ranged between a loss of 682.3 Mb (~24% of the genome) and a gain of 1,958.6 Mb (~69% of the genome). Recurrent gains included 2pter‑q22.1, 3q26.1‑qter, 5pter‑p12, 7p22.3p14.1, 8p12p11.22, 8q24.13q24.3, 11q13.2q13.4, 12pter‑p12.2, 18pter‑p11.31 and 20p13p12.1, whereas recurrent losses included 3pter‑p21.32, 4q28.1‑q35.2, 5q13.2‑qter, 9pter‑p21.3 and monosomy 13. Gains of 3q26.1‑qter were associated with tumor stage, poor differentiation and smoking history. Additionally, through integration with bioinformatic analysis of data from the GEO database, putative target oncogenes, including sex‑determining region Y‑box 2, eukaryotic translation initiation factor 4 gamma 1, fragile X‑related gene 1, disheveled segment polarity protein 3, defective n cullin neddylation 1 domain containing 1, insulin like growth factor 2 mRNA binding protein 2 and CCDC26 long non‑coding RNA, and tumor suppressor genes, such as CUB and sushi multiple domains 1, cyclin dependent kinase inhibitor 2A, protocadherin 20, serine peptidase inhibitor Kazal type 5 and Nei like DNA glycosylase 3, were identified in supraglottic LSCC. Supraglottic LSCC is a genetically complex tumor type and aCGH was demonstrated to be effective in the determination of molecular profiles with higher resolution. The present results enable the identification of putative target oncogenes and tumor suppressor gene mapping in supraglottic LSCC.Keywords
This publication has 49 references indexed in Scilit:
- Humoral Autoimmune Response to IGF2 mRNA‐Binding Protein (IMP2/p62) and Its Tissue‐Specific Expression in Colon CancerScandinavian Journal of Immunology, 2013
- DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAsProceedings of the National Academy of Sciences, 2012
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell CarcinomasPLOS ONE, 2010
- Origins and functional impact of copy number variation in the human genomeNature, 2009
- Classification of human cancers based on DNA copy number amplification modelingBMC Medical Genomics, 2008
- Frequent Silencing of the Candidate Tumor Suppressor PCDH20 by Epigenetic Mechanism in Non–Small-Cell Lung CancersCancer Research, 2006
- High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism MarkersCancer Research, 2006
- Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic featuresJournal of Medical Genetics, 2004
- Amplification of the 3q26.3 Locus Is Associated with Progression to Invasive Cancer and Is a Negative Prognostic Factor in Head and Neck Squamous Cell CarcinomasThe American Journal of Pathology, 2002